Back to search results

The PAYMENT Trial: Financial Support for Early-Stage Cancer Patients

This study, called the PAYMENT Trial, is looking at whether giving early-stage cancer patients unrestricted cash payments can help with financial and health outcomes. A cancer diagnosis can cause financial stress, leading to problems like lower quality of life and difficulty following treatment plans. This trial wants to see if providing financial support can help patients avoid these issues. You might be able to join if you are an adult (18 or older) who understands English, can sign a consent form, and have been recently diagnosed with a non-metastatic or early-stage solid tumor. The study aims to enroll 20 patients and will track how quickly people join and if anyone drops out.

Study design
This is an interventional study where patients are randomly assigned to one of two groups. One group receives a $1000 preloaded cash card each month for three months, and the other group receives a $100 preloaded cash card each month for three months.
What's involved
You would receive a preloaded cash card monthly for three months. You would also participate in ancillary studies, which include electronic health record reviews, interviews, and surveys.
Compensation
Participants in Arm A will receive a $1000 preloaded cash card monthly for three months. Participants in Arm B will receive a $100 preloaded cash card monthly for three months.
Follow-up
After the three months of receiving the cash card, patients will be followed up at 3 months and 6 months after they were first assigned to a group.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06771739

A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial

Recruiting
NAAges 18+InterventionalHealth services
Fred Hutchinson Cancer Center
~20 participants
Updated 2026-09-03 on ClinicalTrials.gov
What's tested:Electronic Health Record ReviewInterviewSupportSurvey Administration

At a glance

Recruiting sites
2 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Participant enrollment
Measured over Up to 1 year
+3 more outcomes measured

Conditions

Malignant Solid Neoplasm

Explore related trials

Solid Neoplasm

NCT06771739

Where you'd take part

This study runs at 3 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • PeaceHealth Saint Joseph Medical Center

    Bellingham, Washingtonno site contact published

    Not yet recruiting

  • PeaceHealth Southwest Medical Center

    Vancouver, Washingtonno site contact published

    Recruiting

  • PeaceHealth St. John Medical Center

    Longview, Washingtonno site contact published

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Veena Shankaran, MD · PRINCIPAL_INVESTIGATOR · Fred Hutch/University of Washington Cancer Consortium

Who to contact

Ari Bell-Brown
[email protected]
206-667-7624
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age \>= 18
Ability to understand English
Ability to understand and willingness to sign a written informed consent document. Legally authorized representatives may sign and give informed consent on behalf of study participants
Within 90 days of a non-metastatic or early-stage solid tumor receiving or rescheduled to receive treatment in the neoadjuvant, adjuvant or definitive setting for curative intent. Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
Current cancer patient at PeaceHealth (Southwest Medical Center or St. Joes)
Not current Medicaid enrollee
Not enrolled in hospice
Screens positive for financial fragility

What this trial measures

  • Participant enrollmentUp to 1 year

    Feasibility will be measured by participant enrollment (percent enrolled versus \[vs.\] approached). The study will be considered feasible to implement if 60% or more of approached patients enroll.

  • Time to accrue 20 patientsUp to 1 year

    Feasibility will be measured by the time in months to accrue 20 patients. The study will be considered feasible if accrual is reached by 6 months.

  • Dropout rateUp to 1 year

    Feasibility will be measured by dropout during study period. The study will be considered feasible to implement if less than 20% of patients drop out. Will be able to estimate a drop-out rate of 20% to within a 95% confidence interval of +/- 18%.

  • Survey completion rateUp to 1 year

    Feasibility will be measure by rates of survey completion. The study will be considered feasible to implement if survey completion is 90% or greater.